← Back to Search

SMS Intervention for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Waitlist Available
Led By Joseph Biederman, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Proficient in English
Male and female adults 18 to 55 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights
No Placebo-Only Group

Study Summary

This study will assess the efficacy of the text messaging (SMS-based) disease management intervention to improve adherence to stimulants in adults with Attention Deficit/Hyperactivity Disorder (ADHD). Participants in the study will receive customized text messages twice a day, every day, for a duration of 9 months. The text messages will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment.

Eligible Conditions
  • Attention Deficit Hyperactivity Disorder (ADHD)

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to Stimulants

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: SMS InterventionExperimental Treatment1 Intervention
All subjects will receive customized text messages twice a day, every day for 9 months that will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,898 Previous Clinical Trials
13,184,061 Total Patients Enrolled
59 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
8,408 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
ShireIndustry Sponsor
456 Previous Clinical Trials
97,426 Total Patients Enrolled
72 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
16,116 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Joseph Biederman, MDPrincipal InvestigatorMassachusetts General Hospital
24 Previous Clinical Trials
6,309 Total Patients Enrolled
13 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
4,379 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Alabama
Illinois
Michigan
How old are they?
18 - 65
What site did they apply to?
Massachusetts General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
1
~15 spots leftby Feb 2025